IND Submissions Explained: Complete Guide to FDA Investigational New Drug Applications Mastering IND Applications: Compliance-Driven Roadmap for Successful FDA Submissions Introduction to IND and Its Importance An Investigational New Drug (IND) application is a regulatory submission to the U.S. Food and Drug Administration (FDA) that allows sponsors to begin human clinical trials for new drugs or biologics. Without an effective IND, clinical trials in the U.S. cannot legally proceed. The IND ensures that the investigational product is safe for initial use in humans and that trial protocols are scientifically sound and ethically designed. The IND represents a critical milestone in…